Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
Harvard University · Beth Israel Deaconess Medical Center · +10 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,028
total citations
- FWCI
- 50.46
- Percentile
- 100%
- References
- 43
Citations per year
Authors
18- JZJinfang ZhangCorresponding
Harvard University, Beth Israel Deaconess Medical Center
- XBXia Bu
Harvard University, Dana-Farber Cancer Institute
- HWHaizhen Wang
Harvard University, Dana-Farber Cancer Institute
- YZYasheng Zhu
Changhai Hospital, Second Military Medical University
- YGYan Geng
Harvard University, Dana-Farber Cancer Institute
Topics & keywords
Topics
Keywords
- Cullin
- Cancer research
- Ubiquitin ligase
- PD-L1
- Immune checkpoint
- Cyclin-dependent kinase 6
- Durvalumab
- Protein degradation
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.